Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Pan American Silver Corp. Common Stock (PAAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Pan American Silver Corp. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Pan American Silver Corp. Common Stock trades at $46.27 (market cap $18.72B). The key difference: Pan American Silver Corp. Common Stock is the larger of the two by market cap, and Pan American Silver Corp. Common Stock pays a 1.62% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Pan American Silver Corp. Common Stock for 1 Days on average.
| HALO | PAAS | |
|---|---|---|
Market Cap | $12.58B | $18.72B |
Volume | 2,179,278 | 2,957,838 |
Sector | Health | Basic Materials |
52-Week High | $115.22 | $68.70 |
52-Week Low | $61.63 | $33.20 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $17.86B |
Dividend Yield | — | 1.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Pan American Silver Corp. Common Stock
Pan American Silver is a mining company focused on silver and gold production in the Americas. It also explores and develops precious metals properties.
Read more on PAAS →
